Ohio, and Brad Finstad, R-Minnesota, last week introduced the bicameral Main Street Lending Improvement Act of 2025, which ...

President Donald Trump signed an executive order that puts in motion the reclassification of marijuana as a Schedule III drug ...

Congressman Dave Taylor (OH-02) and Congressman Brad Finstad (MN-01) today introduced the bicameral Main Street Lending Improvement Act of 2025, which would require a study on the Small Business ...

Canada has long been a desirable location for international students. Hear firsthand from business school students about what studying in Canada is really like ...

The change would not legalize the drug on the federal level, but would ease barriers on research using cannabis.

The U.S. Food and Drug Administration has delayed a review of safety data for the abortion drug mifepristone at Commissioner ...

Geneticist Michael Klotsman was frustrated by human drug development. That led him to launch a startup focused on treatments ...

The Maryland House voted on Tuesday to override a veto imposed by Democratic Governor Wes Moore and to set up a commission to ...

Lawmakers approved bills to study the cost of climate change and the impact of data centers, and establish a new energy ...

LTR Pharma has received an early Christmas present with the Therapeutic Goods Administration (TGA) providing regulatory ...

Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in dogs, has received MUMS designation for minor use in a major species from ...

President Donald Trump is expected to sign an executive order rescheduling marijuana as a Schedule III drug. How's it different from legalizing weed?